Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
How AI is Delivering Real Mission Results Across Government
Workforce training and software development are some areas where agencies are using AI to save time, modernize systems and improve services.
3m read -
DOT's Vision for AI-Powered Digital Corridors for Interstate Travel
The agency wants digital transportation infrastructure that uses AI and shared data to improve traffic management, safety and travel.
3m read -
Inside DOE's Effort to Use AI for Nuclear Waste Cleanup
Eric Pierce explains how Savannah River National Laboratory is using AI to modernize environmental monitoring and waste cleanup.
12m listen -
Federal Cyber Leaders Grapple With Growing Nonhuman Identity Risks
Federal leaders said AI agents, service accounts and API keys are creating new vulnerabilities across government networks.
3m read
